Haili Qian

State Key Laboratory Of Molecular Oncology, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Targeting enolase isoenzyme 2 enables precision glycolysis inhibition in VHL-mutant renal cell carcinoma.

Targeting enolase isoenzyme 2 enables precision glycolysis inhibition in VHL-mutant renal cell carcinoma.

Journal: Cell death & disease

Published: December 13, 2025

STS2 deficiency revives CD8+T cells from exhaustion and augments checkpoint blockade efficacy in cancer immunotherapy.

STS2 deficiency revives CD8+T cells from exhaustion and augments checkpoint blockade efficacy in cancer immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: May 29, 2025

Systemic immune characteristics predicting toxicity to immune checkpoint inhibitors in patients with advanced breast cancer.

Systemic immune characteristics predicting toxicity to immune checkpoint inhibitors in patients with advanced breast cancer.

Journal: Journal of autoimmunity

Published: January 30, 2025

Build the virtual cell with artificial intelligence: a perspective for cancer research.

Build the virtual cell with artificial intelligence: a perspective for cancer research.

Journal: Military Medical Research

Published: January 02, 2025

A cohort-based multi-omics identifies nuclear translocation of eIF5B /PD-L1/CD44 complex as the target to overcome Osimertinib resistance of ARID1A-deficient lung adenocarcinoma.

A cohort-based multi-omics identifies nuclear translocation of eIF5B /PD-L1/CD44 complex as the target to overcome Osimertinib resistance of ARID1A-deficient lung adenocarcinoma.

Journal: Experimental hematology & oncology

Published: December 02, 2024

The N6-methyladenosine writer METTL3 promotes breast cancer progression through YTHDF2-dependent posttranscriptional silencing of GSDMD.

The N6-methyladenosine writer METTL3 promotes breast cancer progression through YTHDF2-dependent posttranscriptional silencing of GSDMD.

Journal: Apoptosis : an international journal on programmed cell death

Published: October 24, 2024

NAD+/SIRT1 pathway regulates glycolysis to promote oxaliplatin resistance in colorectal cancer.

NAD+/SIRT1 pathway regulates glycolysis to promote oxaliplatin resistance in colorectal cancer.

Journal: World journal of gastroenterology

Published: August 27, 2024

LINC01503 in cancer: from molecular mechanisms to therapeutic implications.

LINC01503 in cancer: from molecular mechanisms to therapeutic implications.

Journal: Clinical and experimental medicine

Published: May 07, 2024

Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosis.

Mutations in homologous recombination repair genes in patients with metastatic endometrial cancer: association with clinical characteristics and prognosis.

Journal: Journal of gynecologic oncology

Published: April 16, 2024

Pyrotinib and trastuzumab combination treatment synergistically overcomes HER2 dependency in HER2-positive breast cancer: insights from the PHILA trial.

Pyrotinib and trastuzumab combination treatment synergistically overcomes HER2 dependency in HER2-positive breast cancer: insights from the PHILA trial.

Journal: EBioMedicine

Published: April 05, 2024

Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial.

Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial.

Journal: Nature medicine

Published: February 07, 2024

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy.

Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy.

Journal: Journal of biomedical science

Published: July 14, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026